<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Perspectives on Enquiry & Evidence

Cytel's blog featuring the latest industry insights.

Understanding Market Exclusivity for Orphan Drug Products

Market exclusivity for orphan drugs is a regulatory mechanism designed to incentivize pharmaceutical companies to develop treatments for rare diseases. This exclusivity grants the drug manufacturer a specific period during which no similar medicinal products can be approved for the same therapeutic indication, irrespective of patent status. This period provides a critical market advantage, allowing the company to recover the costs of research, development, and marketing without competitive products.

Read full article
Perspectives on Enquiry and Evidence
contact iconSubscribe back to top